HELLERUP, Denmark, Feb. 26, 2026 /PRNewswire/ -- In accordance with TORM plc's (TRMD) (Nasdaq: TRMD A) Remuneration Policy adopted by the Annual General Meeting of TORM plc on 14 April 2021, the Board ...

COPENHAGEN, Denmark, December 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a long-term incentive program for Executive Management as ...

Zealand Pharma has implemented the LTIP to align with selected European and U.S. biotech peers, with the program designed to drive long-term value creation, align the interests of Corporate Management ...

Members of Hydro’s Executive Leadership Team have received shares in Hydro via the Long-Term Incentive plan and purchased shares via the employee share purchase program. Norsk Hydro ASA has a ...

HELLERUP, Denmark, Sept. 23, 2025 /PRNewswire/ -- In accordance with TORM plc's (TRMD) ("TORM", Nasdaq ticker TRMD or TRMD A) Remuneration Policy adopted by the Annual General Meeting of TORM on 14 ...

Copenhagen, Denmark, April 19, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of ...

Members of Hydro’s Executive Leadership Team have received shares in Hydro via the Long-Term Incentive plan and purchased shares via the employee share purchase program. Norsk Hydro ASA has a ...

Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026 Copenhagen, Denmark, April 19, 2026 – Zealand Pharma A/S ("the ...